Literature DB >> 27229642

Vasopressors During Sepsis: Selection and Targets.

Jean P Gelinas1, James A Russell2.   

Abstract

Clinicians have greatly improved care for septic shock. Urgent resuscitation using intravenous fluids and vasopressors as well as rapid administration of broad spectrum antibiotics are probably the most basic and universally accepted interventions. Various trials have compared different types of vasopressors, associations of vasopressors and inotropes, and pressure targets. End goal-directed therapy algorithms are designed to optimize oxygen delivery by use of fluids, vasopressors, inotropes, and blood products. Patients who have a poor response to resuscitation and patients with known severe ventricular dysfunction might merit advanced hemodynamic monitoring. This review examines important vasopressor and septic shock trials.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dobutamine; Epinephrine; Milrinone; Norepinephrine; Sepsis; Septic shock; Vasopressin; Vasopressors

Mesh:

Substances:

Year:  2016        PMID: 27229642     DOI: 10.1016/j.ccm.2016.01.008

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis.

Authors:  Shigeyuki Yamashita; Tokiko Suzuki; Keisuke Iguchi; Takuya Sakamoto; Kengo Tomita; Hiroki Yokoo; Mari Sakai; Hiroki Misawa; Kohshi Hattori; Toshi Nagata; Yasuhide Watanabe; Naoyuki Matsuda; Naoki Yoshimura; Yuichi Hattori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-20       Impact factor: 3.000

2.  Early administration of dobutamine in the treatment of septic shock patients with tumor-a retrospective comparative cohort study.

Authors:  Ya-Fei Wu; Yin Pan; Qiang Tang; Ning Lou; Dao-Feng Wang
Journal:  Ann Transl Med       Date:  2022-08

Review 3.  Progress in the Clinical Assessment and Treatment of Myocardial Depression in Critically Ill Patient with Sepsis.

Authors:  Xu-Dong Shen; Hua-Sheng Zhang; Rui Zhang; Jun Li; Zhi-Gang Zhou; Zhi-Xian Jin; Yin-Jia Wang
Journal:  J Inflamm Res       Date:  2022-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.